Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03898908
What this trial is testing

Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain

Who this might be right for
Metastatic MelanomaBrain Metastases
Grupo Español Multidisciplinar de Melanoma 48
Not applicableWithdrawnNCT00093678
What this trial is testing

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Who this might be right for
CachexiaLymphomaMelanoma (Skin)+4 more
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT01236573
What this trial is testing

Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes

Who this might be right for
Skin CancerMetastatic Melanoma
National Institutes of Health Clinical Center (CC) 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT03149029
What this trial is testing

Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma

Who this might be right for
Metastatic Melanoma
Massachusetts General Hospital 16
Testing effectiveness (Phase 2)Ended earlyNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 225
Testing effectiveness (Phase 2)Study completedNCT00871481
What this trial is testing

Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
Fred Hutchinson Cancer Center 10
Testing effectiveness (Phase 2)Ended earlyNCT03476174
What this trial is testing

Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma

Who this might be right for
Melanoma
Ralph Hauke 1
Testing effectiveness (Phase 2)Study completedNCT00261404
What this trial is testing

TNFerade™ Biologic Plus Radiation for Metastatic Melanoma

Who this might be right for
Melanoma
GenVec
Not applicableLooking for participantsNCT04045691
What this trial is testing

Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment

Who this might be right for
Melanoma Stage IVMelanoma Stage III
Pierre Fabre Pharma GmbH 750
Testing effectiveness (Phase 2)UnknownNCT02913417
What this trial is testing

Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases

Who this might be right for
Uveal MelanomaHepatic Metastases
David Minor, MD 26
Testing effectiveness (Phase 2)Study completedNCT00679289
What this trial is testing

Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaCutaneous Melanoma
Ludwig Institute for Cancer Research 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT07376317
What this trial is testing

Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS)

Who this might be right for
Melanoma MetastaticMelanoma RecurrentCutaneous Melanoma+1 more
Instituto do Cancer do Estado de São Paulo 29
Testing effectiveness (Phase 2)Study completedNCT03873818
What this trial is testing

Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00288041
What this trial is testing

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+3 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT03620019
What this trial is testing

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Who this might be right for
Melanoma Stage IiiMelanoma Stage IvMelanoma+2 more
UNC Lineberger Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00304525
What this trial is testing

Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Novartis Pharmaceuticals 104
Not applicableStudy completedNCT04760080
What this trial is testing

Association of Hydroxychloroquine, BRAF and MEK Inhibitors in Metastatic Melanoma : a Retrospective Case-control Study.

Who this might be right for
Dermatology and Oncology
Hospices Civils de Lyon 31
Testing effectiveness (Phase 2)Study completedNCT00203879
What this trial is testing

Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
University of Chicago 19
Not applicableStudy completedNCT06180460
What this trial is testing

CALM: Managing Distress in Malignant Brain Cancer

Who this might be right for
Brain TumorBrain MetastasesBrain Cancer+5 more
Virginia Commonwealth University 60
Testing effectiveness (Phase 2)Study completedNCT00104988
What this trial is testing

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network 64
Next Page